Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CsA Ophthalmic Gel in Moderate to Severe ADDE
NCT03676335Phase 2Completed
- Sponsor
- Zhaoke Ophthalmology
- Start
- May 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine 2% ophthalmic solution in dry eye disease (DED), sponsored by Zhaoke Ophthalmology. Started May 2018; status: completed.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03676335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03676335.